White Paper Download:
Using Market Analogs for FP&A During Product Launch

Improve accuracy when determining key sales adjustments

Estimating the value of net sales adjustments from a Finance perspective can be very difficult due to a lack of available internal data and market information. The problem is especially acute before launch and in the first few quarters the product is on the market. 

IntegriChain often provides market-level benchmarks and analogs (i.e., metadata) that can serve as the foundation of a data-driven approach to financial planning & analysis for product launch. Manufacturers adopting this methodology would then have a credible source as the basis for estimating sales adjustments and a methodology that’s been readily accepted by external audit firms.

This white paper examines the use of Market Benchmark data to forecast:

  • Rebates allocation
  • Product returns accruals
  • Wholesaler chargeback accruals
Rg Paper
adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article